Abstract
Salmonella
is estimated to cause over a million infections and ~400 deaths annually in the U.S.
Salmonella enterica
serotype Javiana strains (n = 409) that predominantly originated from the State of Arkansas over a six-year period (2003 to 2008) were studied. This period coincided with a rapid rise in the incidence of
S.
Javiana infections in the U.S. Children under the age of 10 displayed the highest prevalence of
S
. Javiana infections, regardless of sex or year of detection. Antimicrobial susceptibility to 15 different antimicrobials was assessed and 92% (n = 375) were resistant to at least one of the antimicrobials. Approximately 89% of the isolates were resistant to sulfisoxazole alone and 3% (n = 11) were resistant to different antimicrobials, including gentamicin, ciprofloxacin or ceftiofur. The pulsed-field gel electrophoresis (PFGE) analyses assessed the genotypic diversity and distribution of
S
. Javiana strains using
Xba
I restriction. Nine major clusters were identified and isolates from each group were digested with the restriction enzyme
Avr
II. Isolates with identical profiles of
Xba
I and
Avr
II were found to be disseminated in human populations. These distinct “types” of
S
. Javiana were persistent in human populations for multiple years. A subset of isolates (n = 19) with unique resistance phenotypes underwent plasmid and incompatibility (Inc) type analyses and the isolates resistant to more than one antimicrobial harbored multiple plasmids (<3 to 165 kb). Furthermore, these strains possessed 14 virulence genes, including
pagC, cdtB,
and
iroN
. The whole genome sequences (WGS) of 18 isolates that mostly originated from Arkansas from 2003 to 2011 were compared with isolates collected from different areas in the U.S. in 1999, indicating the perseverance of
S
. Javiana in disseminating antimicrobial resistance and virulence genes.